MDT

98.84

+0.35%↑

A

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

A

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

A

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

A

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

A

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

Search

Twist Bioscience Corp

Fermé

SecteurSoins de santé

41.06 2.93

Résumé

Variation du prix de l'action

24h

Actuel

Min

39.77

Max

41.71

Chiffres clés

By Trading Economics

Revenu

-48M

-27M

Ventes

3M

99M

Marge bénéficiaire

-27.41

Employés

979

EBITDA

3.2M

-21M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+8.44% upside

Dividendes

By Dow Jones

Prochains Résultats

2 févr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

462M

2.3B

Ouverture précédente

38.13

Clôture précédente

41.06

Sentiment de l'Actualité

By Acuity

50%

50%

151 / 361 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Very Strong Bearish Evidence

Twist Bioscience Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

14 janv. 2026, 22:41 UTC

Acquisitions, Fusions, Rachats

Canadian Natural Resources, Tourmaline File Deal Notice With Antitrust Regulator

15 janv. 2026, 00:00 UTC

Résultats

Welcome to Greenland, an Economy Reliant on Subsidies and Shrimp -- WSJ

14 janv. 2026, 23:47 UTC

Market Talk

Oil Slips After Trump Appears to Tilt Away From Military Action in Iran -- Market Talk

14 janv. 2026, 23:44 UTC

Market Talk

Nikkei May Decline After Hitting Record Highs; Election in Focus -- Market Talk

14 janv. 2026, 23:39 UTC

Market Talk

ANZ's New Bull Still Sees Valuation Gap to Peers -- Market Talk

14 janv. 2026, 23:32 UTC

Market Talk

Gold Declines on Likely Technical Correction, Possible Profit-Taking -- Market Talk

14 janv. 2026, 22:56 UTC

Acquisitions, Fusions, Rachats

Soho House Amends Rollover and Support Agreements With Broad Street Principal Investments and Others

14 janv. 2026, 22:53 UTC

Acquisitions, Fusions, Rachats

Soho House: Apollo Global Management and Goldman Sachs Asset Management Amend Debt Commitment

14 janv. 2026, 22:17 UTC

Market Talk

Global Equities Roundup: Market Talk

14 janv. 2026, 22:17 UTC

Market Talk

WiseTech's Revenue Growth Drivers Attract Scrutiny -- Market Talk

14 janv. 2026, 22:09 UTC

Résultats

CITIC Securities: Uptrend in China Capital Markets Supported Results >600030.SH

14 janv. 2026, 22:08 UTC

Résultats

CITIC Securities 2025 Oper Rev CNY74.83B Vs. CNY58.12B >600030.SH

14 janv. 2026, 22:08 UTC

Résultats

CITIC Securities 2025 Net CNY30.05B Vs. Net CNY21.57B >600030.SH

14 janv. 2026, 21:53 UTC

Acquisitions, Fusions, Rachats

WuXi XDC Expects 2025 Net to Increase Over 38% on Year

14 janv. 2026, 21:53 UTC

Acquisitions, Fusions, Rachats

WuXi XDC Expects 2025 Revenue to Increase More Than 45% on Year

14 janv. 2026, 21:52 UTC

Acquisitions, Fusions, Rachats

WuXi XDC Announces Positive Profit Alert for 2025

14 janv. 2026, 21:51 UTC

Acquisitions, Fusions, Rachats

Citigroup Acting as Financial Advisor to WuXi XDC

14 janv. 2026, 21:51 UTC

Acquisitions, Fusions, Rachats

WuXi XDC: Aims to Keep Listing Status of BioDlink

14 janv. 2026, 21:51 UTC

Acquisitions, Fusions, Rachats

WuXi XDC: Company to Finance BioDlink Shares Acquisition via Internal Resources

14 janv. 2026, 21:50 UTC

Market Talk
Résultats

Financial Services Roundup: Market Talk

14 janv. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

14 janv. 2026, 21:49 UTC

Acquisitions, Fusions, Rachats

WuXi XDC: BioDlink Offer to Cost HK$2.79B

14 janv. 2026, 21:48 UTC

Acquisitions, Fusions, Rachats

WuXi XDC Offers to Pay HK$4.00 for Each BioDlink International Share

14 janv. 2026, 21:48 UTC

Acquisitions, Fusions, Rachats

WuXi XDC Makes Cash Offer for BioDlink International

14 janv. 2026, 21:13 UTC

Market Talk

Oil Retreats Late After Trump Comments on Iran -- Market Talk

14 janv. 2026, 20:30 UTC

Market Talk
Résultats

Danaher's Preliminary 4Q Seen as Promising -- Market Talk

14 janv. 2026, 20:13 UTC

Market Talk

U.S. Natural Gas Futures Sink Ahead of Storage Report -- Market Talk

14 janv. 2026, 20:08 UTC

Market Talk

Oil Futures Extend Rally on Iran Tensions -- Market Talk

14 janv. 2026, 19:33 UTC

Market Talk

Nutrien Seen as Winner in Tighter 2026 Potash Market, Higher Prices -- Market Talk

14 janv. 2026, 19:06 UTC

Market Talk
Résultats

Wells Fargo Says Customers, Economy Remain Resilient -- Market Talk

Comparaison

Variation de prix

Twist Bioscience Corp prévision

Objectif de Prix

By TipRanks

8.44% hausse

Prévisions sur 12 Mois

Moyen 41.25 USD  8.44%

Haut 43 USD

Bas 39 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

5 ratings

5

Achat

0

Maintien

0

Vente

Score Technique

By Trading Central

31.56 / 38.6884Support & Résistance

Court Terme

Very Strong Bearish Evidence

Moyen Terme

Bearish Evidence

Long Terme

Bearish Evidence

Sentiment

By Acuity

151 / 361Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Moyen

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Twist Bioscience Corp

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
help-icon Live chat